Pr of Oncology
MD, PhD
Head of Clinical & Translational Immunotherapies. UMC (University MC), Utrecht (NL); Chief Scientific Officier. Pediatric oncology center Princessa Maxima, Utrecht. (NL)
Past President of EORTC, ECCO, of the European Academy of Cancer Sciences.
Past CEO Gustave Roussy. Eur J Cancer Editor in Chief
Brenus’ manufacturing process overpasses the lack of immunogenicity & educates the immune system with visible and multi-specific targets
Selection criteria of starting material (Allogeneic tumor cell lines)
Brenus’ manufacturing process overpasses the lack of antigenicity & educates the immune system with a broad & higher quality range of tumor antigens